HUL share price target 2026: 9-23% upside on rural demand

Why HUL is still trading in a tight range

Hindustan Unilever (HUL) has spent much of the last 18 months moving within a broad band of ₹2,100 to ₹2,780. The market’s focus has stayed on one core variable: rural demand. For a staples company where volumes matter as much as pricing, investors have been looking for evidence that rural consumption is recovering enough to lift volume growth meaningfully.

As of April 2026, the stock is referenced around ₹2,200 in the target discussion, with analysts projecting upside that depends on a combination of demand recovery, input-cost normalisation, and premium portfolio outperformance. The near-term setup, the 12-month consensus, and the longer-term targets all circle back to the same question: when does volume growth re-accelerate, and can margins expand alongside it?

Where the stock traded recently: key price datapoints

The dataset includes multiple market snapshots showing the stock near its 52-week lows in March 2026, and separate references to later prices as well. In one update, Hindustan Unilever’s share price is noted as down 0.93% from a previous close of ₹2,074.40, with the last traded price at ₹2,055.20.

Another exchange-style snapshot dated 23-Mar-2026 (10:59:42 IST) shows HINDUNILVR at ₹2,042.40, down ₹40.30 or 1.93%, with the day’s low at ₹2,036.00 and high at ₹2,068.90. These levels are important because they also match the cited 52-week low date.

Short-term view (3-6 months): ₹2,200-₹2,400

The stated short-term target band is ₹2,200 to ₹2,400 over 3 to 6 months. The specific near-term catalyst mentioned is Q4 FY26 results (April 2026). The condition attached is clear: if volume growth accelerates to about 5-6%, the stock would likely re-rate toward ₹2,400.

This framework links price action to operating momentum rather than a pure valuation call. It also implies that the stock’s next move depends on volume growth, not just price hikes, which has been a key debate point for consumer staples in recent quarters.

12-month consensus target: ₹2,400-₹2,700 and 9-23% upside

The 12-month analyst consensus target range is ₹2,400 to ₹2,700. From the referenced ₹2,200 level, this implies 9% to 23% upside. The targets quoted include UBS at ₹2,700, Morgan Stanley at ₹2,500, and Motilal Oswal at ₹2,400.

Other target prices in the data are higher, including a “Buy Hindustan Unilever; target of ₹2,910” attributed to Anand Rathi, and an “Accumulate” with target ₹2,772 attributed to Prabhudas Lilladher. ICICI Securities is also cited with CMP ₹2,572 and a target price of ₹2,850, which is described as 11% upside.

Long-term target (2027-2028): ₹2,800-₹3,200 and the conditions attached

The long-term target range provided is ₹2,800 to ₹3,200 for 2027-28. Unlike the 12-month range, this long-term band comes with explicit operating assumptions: volume growth of 7-9%, EBITDA margin at 24% or higher, and premium mix contribution reaching 35% of revenue.

The same dataset also notes a broad range of analyst estimates, with a maximum estimate of ₹3,200 and a minimum estimate of ₹1,966. These figures show the dispersion in views, especially when the market is still waiting for clearer signs of volume acceleration.

What analysts say will drive a re-rating

Across the targets and the explanatory notes, three drivers are repeatedly highlighted. First is rural demand pick-up that can translate into better volume growth. Second is gross margin expansion driven by raw material normalisation. Third is the mix shift, where premium portfolio volume growth outpaces the base portfolio.

This matters for HUL because mix and margins can support profit growth even when headline revenue growth is modest. But the framework here still anchors on volumes as the trigger that can change the market’s willingness to pay up.

Recent fundamentals referenced: Q2 FY26 performance

One business update states that HUL posted a 1% revenue rise to ₹155 billion in Q2 FY26, and that it missed expectations. Normalising the revenue figure to ₹ crore, ₹155 billion equals ₹15,500 crore. EBITDA margin in that quarter is stated at 22.9%.

The same line also mentions a target price increase to ₹2,910, reinforcing that some broker views are leaning more optimistic even while near-term growth is described as subdued.

Key market metrics and 52-week levels in the dataset

The market snapshot lists market cap at ₹4,87,540 crore, ROE of 22.35%, and P/E (TTM) at 33.53. It also includes EPS (TTM) of 61.88, P/B of 10.01, dividend yield of 2.55%, and book value of 207.34.

On the price range, the 52-week high is given as ₹2,750 (04-Sep-2025) and the 52-week low as ₹2,036 (23-Mar-2026). These anchors are consistent with the narrative of a stock that has struggled to hold higher multiples without a clearer volume recovery.

Summary table: price levels, targets, and triggers

Market impact: why the stock is range-bound

The range-bound behaviour described in the data reflects a market that is not willing to price in a strong volume upcycle yet. Targets are being pitched on margin normalisation and premium-led growth, but the rerating trigger is still tied to volume growth thresholds of 5-6% in the near term and 7-9% over the longer term.

The dispersion between targets like ₹2,400 and ₹2,910 also indicates that investors are balancing near-term execution against the longer runway in premium categories. Until rural demand recovery shows up consistently in volumes, the stock’s upside case remains conditional in the way the targets are framed.

Conclusion: what to watch next

HUL’s stated 12-month target range of ₹2,400-₹2,700 implies 9-23% upside from the ₹2,200 reference level, with the near-term band at ₹2,200-₹2,400. The catalysts mentioned are volume growth acceleration, margin improvement from raw material normalisation, and premium mix expansion.

The next widely referenced checkpoint in the dataset is Q4 FY26 results (April 2026). Investors will be watching whether volumes move toward the 5-6% zone that the short-term rerating case depends on, and whether margins sustain an upward trajectory from current levels like the 22.9% EBITDA margin cited for Q2 FY26.